Study of Trypanosoma cruzi Trans-Sialidase and Camelid Antibodies
Author Information
Author(s): Laura Ratier, Mariela Urrutia, Gastón Paris, Laura Zarebski, Alberto C. Frasch, Fernando A. Goldbaum
Primary Institution: Instituto de Investigaciones Biotecnológicas-Instituto Tecnológico de Chascomús (IIB-INTECH), Universidad Nacional de General San Martín-CONICET, Buenos Aires, Argentina
Hypothesis
Can single-domain camelid antibodies effectively inhibit the trans-sialidase activity of Trypanosoma cruzi?
Conclusion
The study found that while camelid antibodies can inhibit recombinant trans-sialidase, they are less effective against the natural enzyme due to genetic diversity within the enzyme family.
Supporting Evidence
- Camelid antibodies showed strong inhibition of recombinant trans-sialidase.
- The antibodies failed to inhibit the enzymatic activity of natural TcTS from T. cruzi.
- Different recombinant TcTS enzymes were inhibited to varying extents by the llama antibodies.
Takeaway
Researchers used llama antibodies to try to stop a parasite's enzyme, but the parasite has many different versions of that enzyme, making it hard to block completely.
Methodology
Llamas were immunized with recombinant trans-sialidase, and single-domain antibodies were obtained through phage display selection.
Limitations
The antibodies were unable to inhibit the natural enzyme due to post-translational modifications and genetic diversity among enzyme variants.
Participant Demographics
Two llamas were used in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website